Steminent Biotherapeutics (ROCO:7729) Change In Inventory: NT$-7.45 Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:7729 Steminent Biotherapeutics Inc ROCO:7729
19 GF Score
Price NT$78.60
! 4 Warning Signs
View Full Analysis

What is Steminent Biotherapeutics Change In Inventory?

Steminent Biotherapeutics ROCO:7729 +0.90% 19 Change In Inventory is NT$-7.45 Mil as of Jun. 2026. GuruFocus rates ROCO:7729 with a GF Score™ of 19/100. The stock has 4 warning signs investors should review.

Steminent Biotherapeutics's change in inventory for the quarter that ended in Jun. 2026 was NT$-4.74 Mil. It means Steminent Biotherapeutics's inventory increased by NT$4.74 Mil from Dec. 2025 to Jun. 2026 .

Steminent Biotherapeutics's change in inventory for the fiscal year that ended in Dec. 2025 was NT$-1.91 Mil. It means Steminent Biotherapeutics's inventory increased by NT$1.91 Mil from Dec. 2024 to Dec. 2025 .

Steminent Biotherapeutics's Total Inventories for the quarter that ended in Jun. 2026 was NT$15.86 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Steminent Biotherapeutics's Days Inventory for the quarter that ended in Jun. 2026 was 716.74.

Inventory Turnover measures how fast the company turns over its inventory within a year. Steminent Biotherapeutics's Inventory Turnover for the quarter that ended in Jun. 2026 was 0.25.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Steminent Biotherapeutics  (ROCO:7729) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Steminent Biotherapeutics's Days Inventory for the quarter that ended in is calculated as:

Days Inventory=Average Total Inventories/Cost of Goods Sold*Days in Period
=15.462/3.937*365 / 2
=716.74

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Steminent Biotherapeutics's Inventory Turnover for the quarter that ended in Jun. 2026 is calculated as

Inventory Turnover=Cost of Goods Sold / Average Total Inventories
=3.937 / 15.462
=0.25

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Steminent Biotherapeutics's Inventory to Revenue for the quarter that ended in Jun. 2026 is calculated as

Inventory-to-Revenue=Average Total Inventories / Revenue
=15.462 / 0
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Steminent Biotherapeutics Change In Inventory Related Terms

Steminent Biotherapeutics Change In Inventory Historical Data

* Premium members only.

The historical data trend for Steminent Biotherapeutics's Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Steminent Biotherapeutics Change In Inventory Chart

Steminent Biotherapeutics Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Change In Inventory
Get a 7-Day Free Trial 0.20 6.93 -4.19 -10.12 -1.91

Steminent Biotherapeutics Semi-Annual Data
Dec20 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
Change In Inventory Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only -5.65 -4.47 0.81 -2.72 -4.74
ROCO:7729
19GF Score
Steminent Biotherapeutics Inc ROCO:7729
Change In Inventory is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Steminent Biotherapeutics Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Jun. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was NT$-7.45 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Change In Inventory →
What does a Change In Inventory of NT$-7.45 Mil mean?
Steminent Biotherapeutics (ROCO:7729) has a Change In Inventory of NT$-7.45 Mil as of Jun. 2026. Change in Inventory is the difference between current-period inventory and past-period inventory. View historical data for Steminent Biotherapeutics and its competitors.
Is Steminent Biotherapeutics' Change In Inventory too high?
Steminent Biotherapeutics' current Change In Inventory is NT$-7.45 Mil. Overall, Steminent Biotherapeutics has a GF Score™ of 19/100, reflecting its overall financial health beyond just this single metric.
How does Steminent Biotherapeutics' Change In Inventory compare to VRTX and REGN?
Steminent Biotherapeutics' Change In Inventory of NT$-7.45 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Change In Inventory for a Biotechnology company?
A good Change In Inventory depends on the Biotechnology industry context. However, Change In Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Change In Inventory mean?
A high Change In Inventory can signal that a stock is expensive relative to its fundamentals. Change in Inventory is the difference between current-period inventory and past-period inventory. View historical data for Steminent Biotherapeutics and its competitors. Steminent Biotherapeutics's current Change In Inventory is NT$-7.45 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Steminent Biotherapeutics stock overvalued right now?
Steminent Biotherapeutics (ROCO:7729) has a current Change In Inventory of NT$-7.45 Mil. The current Change In Inventory is NT$-7.45 Mil. Steminent Biotherapeutics' overall GF Score™ is 19/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Change In Inventory calculated?
Change In Inventory is calculated from a company's financial statements. For Steminent Biotherapeutics (ROCO:7729), the current Change In Inventory is NT$-7.45 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Steminent Biotherapeutics Business Description

Address No.16,Wenhu Street, Neihu District, Taipei, TWN, 11445
Steminent Biotherapeutics Inc is a international stem cell biopharmaceutical company which has stable and efficient stem cell platform technology, aiming to develop live cell drugs to treat degenerative diseases as well as acute and life-threatening diseases. With its Stemchymal which is proprietary technology platform generating the standardized, clinical grade, allogeneic stem cells isolated from human adipose tissue. It is operated in strict compliance to regulations of Taiwan, the US, and Japan.
19GF Score

Get the complete analysis for ROCO:7729

Change In Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$78.60
Price